Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study.

BACKGROUND The optimal duration of thromboprophylaxis after major orthopedic surgery is controversial. Although oral anticoagulants are still widely used for the prevention of venous thromboembolism after hip replacement, to our knowledge no study has assessed the benefit of prolonging anticoagulation beyond the hospital stay. METHODS Consecutive patients who had received warfarin sodium prophylaxis after total hip arthroplasty were randomized to stop taking the drug at the time of hospital discharge or to continue taking it for 4 more weeks. The rate of symptomatic and asymptomatic venous thromboembolic events (as shown by compression ultrasonography of the proximal-vein system) occurring during the study period was compared between the 2 groups. The study was prematurely terminated after the inclusion of the first 360 patients because a statistically significant and clinically relevant superiority of extended over short-term thromboprophylaxis was observed. RESULTS Objectively confirmed venous thromboembolic complications were recorded in 10 patients: 9 (5.1%) in the group of 176 control patients, and 1 (0.5%) in the group of 184 patients who continued the warfarin treatment. The absolute difference in the incidence of events was 4.57% (95% confidence interval [CI], 1.15-7.99). The relative risk of venous thromboembolism developing in control patients compared with patients assigned to extended thromboprophylaxis was 9.4 (95% CI, 1.2-73.5). The number needed to treat was 22. Major bleeding developed in 1 patient who was randomized to the extended prophylaxis group (0.5%; 95% CI, 0.02-3.0) compared with none in the control group. CONCLUSION Extending prophylaxis with warfarin for a few more weeks beyond the hospital stay has the potential to considerably improve the outcome of patients who undergo hip arthroplasty.

[1]  P. Prandoni,et al.  The Value of Ultrasound Screening for Proximal Vein Thrombosis after Total Hip Arthroplasty , 2001, Thrombosis and Haemostasis.

[2]  J. Douketis,et al.  Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials , 2001, The Lancet.

[3]  A. Cohen,et al.  Extended Thromboprophylaxis with Low Molecular Weight Heparin Reduces Symptomatic Venous Thromboembolism following Lower Limb Arthroplasty - a Meta-analysis , 2001, Thrombosis and Haemostasis.

[4]  T. Whitsett,et al.  Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement , 2001, The Journal of bone and joint surgery. American volume.

[5]  J. Heit,et al.  Prevention of venous thromboembolism. , 2001, Clinics in geriatric medicine.

[6]  A. Stephens,et al.  Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease. , 2001, Thrombosis and haemostasis.

[7]  C. Colwell,et al.  Prevention of venous thromboembolism. , 1994, Chest.

[8]  P. Romano,et al.  Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty , 2000 .

[9]  C. Francis,et al.  Low-molecular-weight heparin prophylaxis using dalteparin Extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients : A double-blind, randomized comparison , 2000 .

[10]  B. Morrey,et al.  Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement , 2000, Annals of Internal Medicine.

[11]  C. Francis,et al.  Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. , 2000, Archives of internal medicine.

[12]  J. Caprini,et al.  The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. , 1999, Journal of vascular surgery.

[13]  C. Colwell,et al.  Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. , 1999, The Journal of bone and joint surgery. American volume.

[14]  G. Punzi,et al.  Prolonged Prophylaxis with Unfractioned Heparin Is Effective to Reduce Delayed Deep Vein Thrombosis in Total Hip Replacement , 1998, Respiration.

[15]  M. Gent,et al.  Accuracy of screening compression ultrasonography and clinical examination for the diagnosis of deep vein thrombosis after total hip or knee arthroplasty. , 1998, Canadian journal of surgery. Journal canadien de chirurgie.

[16]  W. Bargar,et al.  Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. , 1998, Archives of internal medicine.

[17]  J. Hirsh,et al.  The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin: A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty , 1998 .

[18]  A. Nielsen,et al.  Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study. , 1998, Thrombosis research.

[19]  K. Chillag.  Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. , 1998, The Journal of bone and joint surgery. American volume.

[20]  M. Gent,et al.  Ultrasonographic Screening before Hospital Discharge for Deep Venous Thrombosis after Arthroplasty: The Post-Arthroplasty Screening Study: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[21]  G. Raskob,et al.  Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. , 1997, Archives of internal medicine.

[22]  H. Arnesen,et al.  Prolonged Thromboprophylaxis Following Hip Replacement Surgery – Results of a Double-blind, Prospective, Randomised, Placebo-controlled Study with Dalteparin (Fragmin®) , 1997, Thrombosis and Haemostasis.

[23]  D. Bergqvist,et al.  Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. , 1996, The New England journal of medicine.

[24]  A. Planès,et al.  Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo , 1996, The Lancet.

[25]  W. Geerts,et al.  Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. , 1996, Annals of internal medicine.

[26]  J. van der Meer,et al.  Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement? , 1995, Thrombosis and Haemostasis.

[27]  J. Hirsh,et al.  Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.

[28]  G. Bannister,et al.  Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. , 1995, The Journal of bone and joint surgery. British volume.

[29]  G. Raskob,et al.  A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis Against Deep-Vein Thrombosis After Hip or Knee Implantation , 1994 .

[30]  H. Büller,et al.  Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis , 1994, The Lancet.

[31]  J. Heit,et al.  RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group. , 1994, The Journal of bone and joint surgery. American volume.

[32]  G. Agnelli,et al.  Features of Thrombi and Diagnostic Accuracy of Impedance Plethysmography in Symptomatic and Asymptomatic Deep Vein Thrombosis , 1993, Thrombosis and Haemostasis.